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betics and mean lesion length was 25.3i12.1 mm. Mean radiation dose was 21.5ti.3 
Gy. According to the Mehran classification of in-stent restenosis only 4.73b represented 
focal lesions -10 mm of length (class I), 69.5% were diffuse lesions (class II to Ill), and 
4.6% of the vesaeis were totally occluded (class IV). After 6 months all patients under- 
went angiographicfollow up (AFU). Binary restenosis was observed in 21 (20%) patients. 
Analysis of the length of the remaining lesion in all patients yielded a significantly shorter 
lesion length at AFU. In those 20 patients with significant restenosis lesion length was 
also significantly reduced from 35.3e15.7 mm to 10.9A5.1 mm (p<O.Ol). In addition we 
observed a significant downgrading of the remaining lesions towards less diffuse and 
more focal lesions (class I63.6%, class 11-111 6.7%, class IV 4.7%; p<O.Ol). 
Conclusion: IRT is a safe and effective tool for the treatment of diffuse in-stent resteno- 
sis. even in those cases with an apparent treatment failure, IRT leads to a shift in the pat- 
tern of recurrent stenosis towards a less diffuse and more focal stenosis which may be 
more suitable for the treatment with conventional interventional techniques. 
1077-4 Effects of Geographic Miss During lntracoronary 
Brachytherapy on Edge Stenosis at Follow-Up 
Rgn~@&, Ralner Schmid, Paul Wexberg, Christian Kirfsits. Stefan Denk, Gilbeti 
Beran, Peter Siostrzonek, Michael Gottsauner-Wolf, Irene Lang, Boris Pokrajac, Richard 
Poetter, Dietmar Glogar, Vienna University Hospital, Vienna, Austria. 
Background: Previous studies have described intracoronary brachytherapy (ICE) to be 
an effective strategy for the reduction of instent restenosis. However, the occurrence of 
edge stenosis after ICB is still a limitation. A possible explanation might be by an insuffi- 
cient irradiation of injured segments. This study aims to determine the effects of insuffi- 
cient irradiation of injured segments during ICE on angiographic outcome at follow up 
(FUP). 
Definition: Reference lsodose (RI): >90% of reference dose at lmm vessel wall depth; no 
gecgraphic miss (NGM): complete injured segment covered by RI; partial geographic 
miss (PGM): outmost 4mm of injured segment only partially covered by RI; geographic 
miss (GM): outmost 4mm not covered by RI. 
Methods: Baseline angiograms of patients with instent restenosis undergoing coronary 
reintervention followed by ICB were analyzed. The distances between outmost reinter- 
ventional injury and outmost RI were measured. The median length of all misses (GM 
and PGM) was 4mm. Accordingly, FUP analysis (minimal lumen diameter [MLD] and per- 
cent diameter stenosis [DS]) was performed at the outmost 4mm segment within the 
injured segment in group NGM. In case of outmost RI shorter than the outmost injury 
(GM or PGM), analysis was perfoned at the segment between outmost RI and outmost 
injury, however at a segment of at least 4mm. 
Resui?s: Edge analysis was performed at 216 edges of 109 patients. FUP was available 
for 116 edges (FUP period: 6.9t2.3 months). 66 edges were irradiated with a beta source 
and 26 edges with a gamma source. GM was found at 16 (13.6%) edges, and PGM at 10 
(6.6%) edges. FUP-MLD was 2.0+0.6, 1.6iO.7 and 1.4*0.7mm (p=O.O2) in the groups 
NGM. PGM, GM, and FUP-DS 23.5t24.9, 33.6k19.5 and 40.0*27.4% (p=O.O3) respec- 
tively. Posthoc Bonferroni analysis revealed significant differences between NGM and 
GM for both FUP-MLD (p=O.O2) and FUP-DS (p=O.O4). 
Conclusion: Geographic miss and partial geographic miss are associated with a smaller 
minimal lumen diameter and a higher percent diameter stenosis at follow up at the site of 
the insufficient radiation. This effect was more pronounced in the GM-patient cohort. 
1077-5 Effects of Debulking Before lntracoronary Beta- 
Radiation Therapy for Diffuse In-Stent Restenosis 
Seono_Woolc, Myeong-Ki Hong, Dae Hyuk Moon, Seung Jun Oh, Cheol Whan Lee, 
Jae-Joong Kim, Seung-Jung Park, Asan Medical Center. University of Ulsan, Seoul, 
South Korea. 
Background: The role of debulking before P-radiation therapy (RT) remains to be eluci- 
dated. We evaluated the clinical and angiographic outcomes after b-RT in patients (pts) 
with diffuse in-stent restenosis (ISR), with or without rotational atherectomy before irradi- 
ation. 
Methods: Fii consecutive pts were treated with ‘ssRe.MAGs-filled balloon after rota- 
tional atherectomy and adjunctive balloon angioplasty (phase I). Another 50 consecutive 
pts were treated without prior atherectomy (phase II). The prescribed dose was 150~ at 
1 mm deep into the tissue form balloon-artery interface. 
Results: Baseline clinical characteristics were not different between 2 groups. Prelimi- 
nary clinical and angiographic results were significantly better in pts with prior debulking 
before p-RT. Final results will be presented. 
Conclusion: These results suggest that debulking before RT with ‘ssRe-MAGs-filled bal- 
loon might improve the long-term clinical and angiographic outcomes in pts with diffuse 
ISR. 
Mean lesion length (mm) 
Mean radiation length (mm) 
Distal reference diameter (mm) 
Baseline MLD (mm) 
Final MLD (mm) 
6 months F/U MLD (mm) 
Loss index 
Restenosis rate 
Death or Ml 
Repeat revascularization 
Debulking + RT RT without debulking Pvalue 
(n=50) (n=50) 
25.3 + 12.7 22.9 * 6.6 0.007 
37.6 * 11.2 41.2f10.3 NS 
2.89 * 0.40 2.77 f 0.46 0.157 
0.60 zt 0.44 0.71 f 0.37 0.170 
2.66 f 0.39 2.61 f 0.44 0.363 
2.31 f 0.60 1.61 f 0.92 0.001 
0.17 f 0.31 0.41 * 0.57 0.001 
5/50 (10%) 14/33 (42%) 0.001 
0 0 
1 (2%) 6 (11%) 0.060 
1077-23 Predictors and Prognostic Values of CK-MB Cardiac 
Enzyme Elevation After Coronary Intervention With 
Radiation Treatment in InStent Restenosis 
m, G. Dangas. R. Mehran, A. A. Lansky, G. W. Stone, N. Kipshidze. 
M. Astatkie, M. Hawkey, D. Ashby, M. Mohamed, I. Moussa, M. B. Collins, J. W. Moses, 
M. 8. Leon, Cardiovascular Research Foundation. New York, New York, Lenox Hi// Heart 
& Vascular hsfitute, New York, New York. 
Background: Elevation of serum creatinine kinase-MB (CK-MB) afler percutaneous core- 
nary intervention (PCI) has been associated with increased mortality. We evaluated the 
predictors and prognostic values of CK-MB enzyme elevation after PCI plus radiation for 
in-stent restenosis. 
Methods: All 350 patients who were randomized to gamma-radiation (k-192) treatment 
after successful PCI in the WRIST, GAMMA-I, GAMMA-II and SCRIPP-III were included 
for the analysis. Patients were divided into 3 groups: CK-MB 23 times normal (N=61), 
CK-MB ~3 times normal (N=53). and no CK-MB elevation (N=236). 
Result: Baseline clinical characteristics were similar among the groups except for diabe- 
tes (Table). 
Conclusion: Post-procedural CK-MB elevation after radiation correlates with diabetes, 
long lesion length and long seed length of radiation source. CK-MB elevation is associ- 
ated with higher in-hospital complications and trend toward higher late thrombosis at 6 
months follow-up. 
CK-MB >3 CK-MB c3 No CK-MB P-Value 
times (n=61) times(n=53) Elevation(n=236) 
Diabetes (%) 42.6% 49.1% 30.0% 0.01 
Ref. vessel diameter (mm) 2.6 f 0.5 2.7 zt 0.3 2.7 * 0.5 0.6 
Lesion length (mm) 32.4 f 19.4 21.7 * 15.4 25.5 * 12.7 0.0013 
Seed length (mm) 55.2 + 17.2 47.4 * 17.6 45.2 + 13.9 <O.OOQl 
Final MLD (mm) 2.1 * 0.5 2.3 f 0.4 2.1 * 0.5 0.01 
Atheroablation (%) 26.7% 26.4% 35.4% 0.2 
In-hospital MACE (%) 31 .O% 6.1% 16.2% 0.02 
MACE at 6 months (%) 26.6% 26.9% 19.3% 0.1 
TVR at 6 months (‘%) 13.6% 25.0% 17.6% 0.2 
Death at 6 months (%) 1.7% 3.9% 1.7% 0.5 
Late thrombosis (%) 6.6% 2.0% 1.7% 0.09 
1077-24 lntracoronary Brachytherapy for In-Stent Restenosis: 
Eliminating the Side Branches? 
oohK Naber I Murad Al-Kahni, Katja Brauck. Tom Oberheiden. Holger Eggebrecht, 
Yasser Abdel Rahman, Wolfgang Sauerwein, Raimund Erbel, Dietrich Baumgart, 
Cardio/ogv University of Essen, Essen, Gemany. 
Background: lntracoronaly radiation therapy (IRT) has proven to be highly effective for 
the prevention of recurrent stenosis after percutaneous intervention of in-stent resteno- 
sis. Nevertheless, while the longitudinal dose fall-off in combination with tissue injury may 
increase the restenosis rate in the main vessel, the lateral dose fall-off may especially 
affect sidebranches of the treated vessel. This phenomenon appears not to take place in 
major sidebranches, but has been so far not investigated for small branches which may 
be more likely affected and may then result in a rarefication of the coronary system. 
Methods and Results: 66 consecutive patients who underwent PTCA and adjuvant IRT 
for in-stent restenosis were included. Mean age was 56.1*11.4 years, 13.1% were dia- 
betics and the mean lesion length was 27.3k15.1 mm. Mean radiation dose was 
21.5k2.2 Gy. In these patients all visible sidebranches in the irradiated segment +lOmm 
were analysed visually for patency and ostial stenosis immediately after the intervention 
and at the 6 months angiographic follow up. A range of 3 to 6 sidebranches was analy- 
sed per patient. After 6 months one vessel with a prior very diffuse lesion was totally 
occluded. In the other cases none of the sidebranches in the analysis were affected or 
even showed a significant narrowing in the proximal part. 
Conclusion: The present data do not support the hypothesis that in sidebranches of the 
treated vessel the combination of tissue injury together with the radiation dose fall-off 
leads to deleterious effects that result finally in a rarefication of the coronary vascular 
system. This finding underlines that IRT is a safe and effective tool for the treatment of in- 
stent restenosis. 
1077-25 lntracoronary Ultrasound Assessment of Intermediate 
Coronary Lesions: Comparison With Pressure-Derived 
Fractional Flow Reserve 
Jacek, Darius2 Dudek, Krzysztof Zmudka, Jacek S. Dubiel, JagMonian 
University, Krakow, Poland. 
Background: The criteria for the severity of stenosis in intracoronary ultrasound (ICUS) 
have not been objectively defined. However, ICUS-derived minimal luminal cross-sec- 
tional area (LAmin,mm’) a4.0 is widely used as the cut-off value for deferral percutane- 
ous coronary intervention in patient with intermediate coronary lesion (IML). Pressure- 
derived fractional flow reserve (FFR) co.75 is strongly related to inducible myocardial 
ischemia. The aim of the study was to evaluate the usefulness of ICUS assessment of 
IML in comparison to FFR. Methods: In 56 patients (pts) with IML (Diameter stenosis 
(DS) =40-60% by QCA) FFR was calculated after intrecoronary injection of adenosine 
(40.6Opg for the left coronary artery, 15-30pg for the right). Than, in all lesions ICUS was 
performed using automated pull-back (0.5mmlsec) to calculate LAmin and the lesion 
length (LL,mm). According to FFR pts were divided into two groups: Group 1: FFRi0.75 
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(12 pts). Group 2: FFRti.75 (44 pts). Results: In pts with reduced FFR (group 1) 
LAminr4.0 mm2 was obtained in 3 pts (25%). Moreover, LAminc4.0 mm’was present in 
16 pts (38%) despite of FFRa0.75 (group 2). The comparison of QCA, FFR and ICUS 
parameters between the two groups is shown in table. Conclusions: ICUS assessment of 
the minimal luminal cross-sectional area has only a limited value in determining the clini- 
cal importance of intermediate coronary lesion. Other factors, such as lesion length may 
also influence functional severity of intermediate coronary lesion. 
Ref.DacA L&A MLDacn D%XA FFR LAmintcus LLICUS 
Group1 3.02Y~O.54 18.3i5.8 1.5Mo.17 49.7f7.0 0.67fo.06 3.20M.45 19.5i7.14 
Group2 3.06iO.38 11.3zk3.9 1.48M.27 51.8f7.8 0.85fo.05 3.74il.01 11.2?5.13 
P= NS 0.018 NS NS 0.0027 0.042 0.0017 
1077-26 Pulse Transmisston Coefficient: A Novel Nonhyperemic 
Index for Physiologic Assessment of Procedural 
Success Following Percutaneous Coronary 
Interventions 
Dsyid&&, Stuart T. Higano. Marvin J. Slepian, Hylton I. Miller, Morton J. Kern, David 
R. Holmes, Jr., Amir Lerman, Mayo Clinic Foundation, Rochester, Minnesota, Saint Louis 
University, Saint Louis, Missouri. 
Background: Coronary lesions may impair the transmission of pressure waves across a 
stenosis, potentially acting as a low-pass filter. The pulse transmission coefficient (PTC) 
is a novel non-hyperemic parameter that calculates the transmission of high frequency 
components of the pressure signal through a stenosis. Thus, it may reflect the severity of 
the coronary artery stenosis, This study was designed to study the change of PTC as 
compared to fractional flow reserve (FFR), following percutaneous coronary intervention 
(PCI). 
Methods: Pressure signals were obtained by pressure guidewire in 27 lesions (27 pts.) 
pre and post PCI, and were analyzed with a new algorithm (Florence Medical Ltd.) that 
identifies the high frequency component in the pressure signal. The PTC was calculated 
as the ratio between distal and proximal high frequency components of the pressure 
waveform across the lesion. FFR measurements were assessed with intracoronary ade- 
nosine. 
Results: There was a significant increase in PTC following PCI (0.12iO.03 at baseline to 
0.95M.01 post PCI; p<O.OOl; Figure). Comparable changes were observed for FFR 
(0.57+0.03 at baseline to 0.91M.01 post PCI; p<O.OOl). 
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Conclusions: PTC is a novel non-hyperemic parameter for physiologic assessment of 
coronary artery stenoses. Similarly to FFR. PTC is significantly increased following PCI. 
Thus, It may serve as an adjunct index for the functional assessment of procedural suc- 
cess following PCI, especially in patients with impaired maximal hyperemia. 
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1076-l 1 Lack of Benefit From Routine Functional Testing 
Among Patients Undergoing Coronary Stenting: 
Insights From the ADORE Trial 
Koon_Hou, Radha Pun, Mark J. Eisenberg, National Heart Centre, Singapore, 
Singapore, Jewish General Hospital, Montreal, Quebec, Canada. 
Background: With increasing number of patients undergoing coronary stenting (CS), the 
role of routine functional testing (FT) is unclear. Our study aims to determine the value of 
this strategy. Mathods: The ADORE Trial randomly assigned 328 patients with success- 
ful coronary angioplasty In 9 countries to selective (clinically ddven) or routine Ff at 6 
weeks, 8 and 9 months after the procedure. Patients were followed-up for adverse clini- 
cal events. The use of invasive and revascluarization procedures were left to the discre- 
tion of the attending physicians. Exercise treadmill testing was performed on all patients 
at 9 months. Resufts: Of 278 (85%) of patients undergoing CS, 148 and 130 of them 
were assigned to the selective and routine groups, respectively. Baseline characteristics 
were similar. Overall, the mean age was 57 years, and 85% of them were male, about a 
sixth had diabetes or prior infarction, and a third had prior angioplasty. Almost 90% of 
patients had single-vessel disease and ~50% had 92/C lesion characteristics. The distri- 
bution of the vessel and number of lesions treated were also similar between the 2 
groups. After a follow-up period of 9 months, the occurrences of adverse events were as 
follows: 
Event Selective Routine 
Death (%) 1 2 
Myocardial Infarction (MI) (%) 2 2 
Unstable angina (UA) (%) 8 10 
Repeat angiography (%) 12 14 
Revascularization (%) 8 12 
Composite (death/UAIMI) (%) 7 6 
Exercise capacity was marginally lower in the selective group (9.4 vs 10.2 METS; 
P=O.O84). Conclusion: Routine FT did not prevent adverse clinical events among 
patients undergoing coronary stenting. 
1078-12 Smoking and Restenosis After Coronary Artery 
Stenting: The Artifact of Smoker’s Paradox 
Julinda, Adnan Kastrati. Josef Dirschinger, Jfirgen Pache, Helmut SchShlen. 
Heidrun Holle, Franz Dotzer, Franz-Josef Neumann, Albert Schomig, Deutsches 
Herzzentrum, Munich, Germany, 1. Med. Klinik rechts der tsar, Munich, Germany 
Background: Cigarette smoking is a strong risk factor for heart disease. Some previous 
studies showed a lower incidence of adverse events and restenosis after percutaneous 
coronary interventions (PCI) in smokers which has since been called the ‘smoker’s para- 
dox’. We investigated the influence of smoking on restenosis after stenting. 
Methods: A consecutive series of 6911 patients who underwent coronary artery stenting 
was analyzed. The follow-up protocol included 8-month angiography (performed in 80% 
of the patients) and a contact 12 months after the procedure. Primary endpoint of the 
study was angiographic restenosis defined as a 2 50% diameter stenosis at follow-up. 
Other endpoints were the combined rate of death or myocardial infarction and the need 
for reinterventions at 1 year. 
Resufts: As shown in the table, the risk profile of the smokers is significantly different 
from that of nonsmokers. Apparently, smokers have a lower risk for restenosis. However, 
the risk reduction disappears after adjustment for baseline characteristics: adjusted odds 
ratio, 0.94 [95% Cl, 0.81-1.091. More importantly, smokers showed a significantly 
increased risk of death or myocardial infarction (adjusted hazard ratio, 1.29 [95% Cl, 
1.03.1.81]). 
Conchtalons: The apparent relation between smoking and a lower restenosis rate after 
PCI is the consequence of more favorable baseline characteristics. Smoking itself has an 
unfavorable influence on the outcome after stenting by increasing the risk of the most 
dreadful events. 
Unlvariate analysis 
Age. yrs 
Women, % 
Diabetes, % 
Multivessel disease, % 
Vessel size, mm 
Angiographic restenosis. % 
Reinterventions, % 
Death or MI, % 
Smokers (n=1848) Nonsmokers (n=5083) 
59tll 67*10 <O.OOl 
18 27 <O.OOl 
15 22 <O.OOl 
67 75 <O.OOl 
3.08*0.51 3.00*0.54 <O.OOl 
28 31 0.04 
17 19 0.13 
8.4 6.9 0.54 
1078-13 Is Direct Stenting an Effective Therapy for Long-Term 
Outcome? Results of the Randomized Bet Study 
&drer Carrie, Khalife Khalife, Bernard Citron, Kari Isaaz, Martial Hamon, Jean M Juliard, 
Elyes El Mokhtar, Jean P Rinaldi, Joelle Fourcade, Remi Sabatier, for the Bet SrUdy 
Group, Toulouse, France. 
Background : The BET (Benefit Evaluation of Direct Coronary Stenting) study is multi- 
venter randomized trial comparing direct (without balloon predilatation) versus conven- 
tional stent implantation (Tenax. Biotronik inc.) to evaluate immediate and long-term 
outomes. 
We have demonstrated that Direct Stenting (DS=) is feasiblesafe, with reduction of pro- 
cedural cost and similar in-hospital clinical outcome. Long-term outcome is unknown and 
no comparison exists with conventional stenting (DS-). 
Methods : 328 randomized patients had a mean clinical follow-up of 16.4 + 4.8 months 
(3.1 - 23.7) which allows to evaluate ma]or adverse cardiac events (MACE) and target 
lesion revascularization (TLR) rates. 
DS (-) DS (+) 
n=181 n=187 
MACE TLR MACE TLR 
3 Months 1.9% 1.2% 1.2 % 0.8 % 
8 Months 5.1 % 3.2 % ns 5.4 % 3.7 % 
12 Months 9.1 % 5.2 % 10.8 % 7% 
More than 18 months 11.3% 5.2 % 18.2 % 7% 
